Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 15, 2020

SELL
$72.92 - $102.01 $277,096 - $387,638
-3,800 Closed
0 $0
Q4 2019

Feb 04, 2020

BUY
$77.66 - $99.74 $295,108 - $379,012
3,800 New
3,800 $351,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track First Dallas Securities Inc. Portfolio

Follow First Dallas Securities Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Dallas Securities Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Dallas Securities Inc. with notifications on news.